Browse 1,492 gastrointestinal clinical trials enrolling across the United States and Canada. 173 people applied to gastrointestinal studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 1,492
Active & Responsive
Genome Analysis Across Populations in Inflammatory Bowel Disease
for
Ulcerative Colitis, Healthy, Crohn Disease,
Location: Toronto
Sponsor: Mount Sinai Hospital, Canada
Sex: All
Age: 0+
Code: NCT06042387
Recruiting
Active & Responsive
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
for
Chronic Pain, Acute Pain, Post Operative Pain,
Location: Providence RI
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT05754190
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis
for
Gastroparesis
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT04434781
Recruiting
Active & Responsive
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
for
Inflammatory Bowel Diseases, Crohn Disease
Location: Vancouver
Sponsor: University of British Columbia
Sex: All
Age: 19 - 70+
Code: NCT06453720
Recruiting
Active & Responsive
A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Boston MA, Brooklyn NY, Laurel MD, Chevy Chase MD,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase 2, Phase 3, Recruiting
Active & ResponsiveNew
taVNS in Infants Severe Dysphagia
for
Dysphagia, Swallowing Disorders,
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 0
Code: NCT07802301
Recruiting
Active & ResponsiveNew
Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors
for
Metastatic Colorectal Cancer (CRC),
Location: Fairfax VA
Sponsor: Ensem Therapeutics
Sex: All
Age: 18+
Code: NCT07912593
Phase 1, Phase 2, Recruiting
Active & ResponsiveNew
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
for
Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer,
Location: Fairfax VA, Orlando FL, Irving TX
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07807345
Phase 1, Recruiting
Active & ResponsiveNew
This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT06559059
Recruiting
Active & Responsive
RCT: Effect of Late vs Early Introduction of Gluten-free Oats on Patients With Newly Diagnosed Celiac Disease.